Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Bruker Acquires DISQVER Clinical Metagenomics Platform | Contract Pharma

What are you searching for?

Sign in
Breaking News

Bruker Acquires DISQVER Clinical Metagenomics Platform

Expands its next-generation sequencing-based infection detection capabilities.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Bruker Corporation has acquired the DISQVER clinical metagenomics platform from Noscendo GmbH.

About the DISQVER Platform

DISQVER enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker’s NGS-based infection detection capabilities.

Without any need for prior cultivation, DISQVER analyzes whole genome sequencing (WGS) data and applies advanced, proprietary bioinformatics to search for more than 11,000 different microbes and parasites. The mNGS analysis can be done directly from cell-free DNA samples from blood, in less than 24 hours after sample receipt. This advanced mNGS clinical research approach can be valuable for bloodstream infections, sepsis, endocarditis and other severe infectious diseases.

“The acquisition of the DISQVER proprietary software and workflow platform is the latest step in our evolution as an innovative microbiology and molecular diagnostics business,” said Dr. Wolfgang Pusch, President of Bruker Microbiology & Infection Diagnostics. “DISQVER adds additional NGS applications to our portfolio for metagenomics, and enhances our support for earlier decision-making in sepsis, bloodstream infections, and severe infections.”

Following the acquisition, DISQVER remains available for research use only, while Bruker is progressing its registration for diagnostic purposes.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics